Vinorelbine and Carboplatin in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Publisher： Karger

E-ISSN： 1423-0232|56|1|24-27

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.1, 1999-01, pp. : 24-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite

Phase II Trial of a Paclitaxel-Carboplatin Combination in Recurrent Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 66-71

Karger

Access to resources Recommend Favorite

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1081-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite